The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Galmed Pharmaceuticals Ltd. - Clinical-Stage Biopharmaceutical Company Focused on Development of Oral Therapy for Liver Diseases

SNNLive spoke with Josh Blacher, CFO of Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) on Thursday, October 15th, 2015 at the Dawson James Small Cap Growth Conference 2015 in Jupiter, FL.

Share With

Wednesday, December 02, 2015

   

© 2017 Stock News Now